Cargando…
Antioxidant Therapy in Cancer: Rationale and Progress
Cancer is characterized by increased oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidants. Enhanced ROS accumulation, as a result of metabolic disturbances and signaling aberrations, can promote carcinogenesis and malignant progression by inducing gene mutations and...
Autores principales: | Luo, Maochao, Zhou, Li, Huang, Zhao, Li, Bowen, Nice, Edouard C., Xu, Jia, Huang, Canhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220137/ https://www.ncbi.nlm.nih.gov/pubmed/35740025 http://dx.doi.org/10.3390/antiox11061128 |
Ejemplares similares
-
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
por: Cao, Jiangjun, et al.
Publicado: (2023) -
Redox signaling at the crossroads of human health and disease
por: Zuo, Jing, et al.
Publicado: (2022) -
Redox Control of the Dormant Cancer Cell Life Cycle
por: Li, Bowen, et al.
Publicado: (2021) -
Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
por: Zhang, Yi, et al.
Publicado: (2022) -
Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs
por: Zhou, Li, et al.
Publicado: (2020)